Low Price Shares locked in Upper Circuit on July 27

low price stocks

Stock Recommendations
by 5paisa Research Team Last Updated: 2022-07-27T13:30:08+05:30

Sensex rises 250 points; Nifty goes above 16,500 level led by capital goods and healthcare stocks. 

Except for Hong Kong's Hang Seng, all major Asian markets were trading higher. The Hang Seng was down more than 1%. With a loss of 60 points, the SGX Nifty indicated a dismal start for India's broader indices. In contrast, Indian headline indices were trading higher as capital goods stocks rose.

List of Low Price Shares Today: July 27

Following is the list of low price stocks locked in the upper circuit on July 27. Keep a close eye on these counters for the upcoming sessions.

Sr No  

Stock Name  

LTP  

Price Change (%)  

1  

Universal Autofoundry  

86.35  

10  

2  

Switching Technology Gunther Ltd  

43.45  

10  

3  

Sovereign Diamonds   

14.85  

10  

4  

Sailani Tours N Travels  

34.36  

9.99  

5  

Pressure Sensitive Systems  

26.02  

9.97  

6  

Suraj Ltd  

70.3  

9.93  

7  

Kenvi Jewels Ltd  

44.3  

9.93  

8  

Kohinoor Foods Ltd  

96.65  

5  

9  

Shri Gang Industries   

87.15  

5  

10  

High Street Filatex  

66.15  

5  

At 12:40 pm, the Nifty 50 was trading at the 16,564.20 level, gaining by 0.49%. On the Nifty 50 index, the top gainers were Divi’s Laboratories, Larsen and Toubro and Grasim Industries whereas Bajaj Auto, Bharti Airtel and Bajaj Finserv were the top losers of the session.

Sensex was trading at a level of 55,547.87, advancing by 0.51%. The top gainers were Larsen and Toubro, Sun Pharmaceuticals and IndusInd Bank whereas Bajaj Finserv, Bharti Airtel and Kotak Mahindra Bank were the market draggers.

The International Monetary Fund (IMF) lowered its prediction of India's gross domestic product (GDP) growth for the current fiscal year by 80 basis points to 7.4%, while rating agency Icra predicted that price erosion pressure would probably lead to slower revenue growth for Indian pharmaceutical companies in the US generics market in FY23.

 

Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Disclaimer

Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.

Open Free Demat Account

& get benefits worth 2100*

 
Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number